Form S-1
Please provide the basis for your statement that you are “at the forefront of technology innovation and thought leadership in automation, creating an end-to-end platform that provides automation with user emulation at its core.” Clarify the criteria on which you base this statement, such as revenue or the number of clients or market share.
“Company”), we are providing this letter supplementally to the U.S. Securities and Exchange Commission’s Division of Corporation Finance (the “Staff”) with information regarding the proposed preliminary price range of the shares of the Company’s Class A common stock to be offered in the proposed initial public offering (“IPO”) pursuant to the Company’s Registration Statement on Form S-1, filed with the U.S. Securities and Exchange Commission on March 26, 2021.One letter for all the questions, without numbered answers. Read the replyRest of the letter
This letter supplements the Company’s response to comment 16 received from the Staff by letter dated January 13, 2021 with respect to the Company’s Draft Registration Statement on Form S-1, as initially confidentially submitted to the Staff on December 17, 2020 (the “Prior Response”). We are providing this information to you supplementally to facilitate your review process. Due to the commercially sensitive nature of information contained in this letter, the Company hereby requests, pursuant to 17 C.F.R. §200.83, that certain portions of this letter be maintained in confidence, not be made part of any public record and not be disclosed to any person. The Company has filed a separate copy of this letter, marked to show the portions redacted from the version filed via EDGAR and for which the Company is requesting confidential treatment. In accordance with 17 C.F.R. §200.83(d)(1), if any person (including any governmental employee who is not an employee of the Commission) should request access to or an opportunity to inspect this letter, we request that we be immediately notified of any such request, be furnished with a copy of all written materials pertaining to such request (including, but not limited to, the request itself) and be given at least ten business days’ advance notice of any intended release so that the Company may, if it deems it to be necessary or appropriate, pursue any remedies available to it. In such event, we request that you telephone the undersigned, as noted below, rather than rely on the U.S. mail for such notice. York, NY 10001-2157 t: (212) 479-6000 f: (212) 479-6275 cooley.com United States Securities and Exchange Commission The Company supplementally advises the Staff that the Company preliminarily estimates that the anticipated price range to be included on the cover of the Company’s preliminary prospectus for its IPO is expected to be within a range of $[***] to $[***] per share of Class A common stock (the “Preliminary IPO Price Range”). As is typical in IPOs, the Preliminary IPO Price Range was not derived using a formal determination of fair value, but was determined by discussions between the Company and the underwriters. The valuation considerations for estimating the Preliminary IPO Price Range were informed by current conditions in the U.S. equity markets, which are continuing to trade at healthy levels and near all-time highs, despite recent volatility in the technology sector, but are subject to future changes or fluctuations. The Preliminary IPO Price Range was derived using a combination of valuation methodologies, including: (1) a comparison of public companies at a similar stage of development; (2) a comparison of valuations for comparable issuers in the Company’s industry, at the time of their IPO; (3) a current analysis of the public equity market by the underwriters for the offering; and (4) the Company’s private placement in February 2021 to certain investors an aggregate of 12,043,202 shares of Series F convertible preferred stock at a purchase price of $62.27576 per share. The estimated fair value stated in the independent common stock valuation report as of February 15, 2021 (the “Contemporaneous February 2021 Valuation Report”) of $[***] falls within the Preliminary IPO Price Range. Any potential discount between the February 15, 2021 estimated fair value and the higher end of the Preliminary IPO Price Range, is immaterial. It is worth noting also that the Preliminary IPO Price Range effectively weighs a near-term IPO outcome at 100%, which would provide the Company with (a) proceeds that substantially strengthen the Company’s balance sheet as a result of increased cash, (b) access to the public company debt and equity markets, and (c) a ‘currency’ to enable the Company to make strategic acquisitions as the Company’s board of directors (the “Board”) may deem appropriate. Fair Value Per Share of Class A Common Stock for Financial Reporting Purposes As noted in the Prior Response, the Board, taking into account the Contemporaneous February 2021 Valuation Report from the specialist valuation practice of a professional third-party valuation firm commissioned by the Board, determined, as of February 15, 2021, that the fair value of the Company’s Class A common stock was $[***] per share. Please refer to the Prior Response for a more fulsome discussion of the Contemporaneous February 2021 Valuation Report. The Company has assessed the fair value of the Company’s Class A common stock for financial reporting purposes in connection with the awards granted after the Contemporaneous February 2021 Valuation Report using a straight-line methodology to interpolate the estimated fair value as of the respective grant dates using the fair value of the Company’s Class A common stock as of February 15, 2021 and the mid-point of the Preliminary IPO Price Range as of the expected date of the IPO, which resulted in the estimated fair values shown in the tables below. Cooley LLP 55 Hudson Yards New York, NY 10001-2157 The Company believes that the fair values determined for the Class A common stock underlying each option grant and restricted stock unit are appropriate and demonstrate the diligent efforts of the Board to consider all relevant factors in determining fair value at each valuation date. Based on the above analysis, the Company believes it has fully complied with all applicable rules and regulations for the determination of fair value, including the best practices outlined in the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation.
We note that you intend to present pro forma net loss per share information, which gives effect to the automatic conversion of your outstanding convertible preferred stock into common stock upon effectiveness of this offering.Rest of the question
Please consider also including the impact of any restricted stock awards that will vest upon this offering along with footnote disclosure regarding the additional share-based compensation that will be recognized at such time. Risks Related to Tax and Accounting Matters We and our independent registered public accounting firm have identified a material weakness in our internal control..., page 47
See the reply above.
You state that you have taken steps to remediate the material weakness in your internal controls such as engaging third-party service providers to assist in technical accounting matters. Please revise to describe what additional steps, if any, management has taken to remediate such weakness and what remains to be completed in your remediation efforts.Rest of the question
Also, disclose how long you estimate it will take to complete your plans and disclose any associated material costs that you have incurred or expect to incur.
See the reply above.
You disclose that annual recurring revenue is defined as “revenue from term subscription licenses and maintenance that you would expect to receive from customers over the following 12 months assuming no increases or reductions in their subscriptions.” You also disclose that you cannot accurately predict renewals given the diversity of your customer base.Rest of the question
Please address the following: • Explain further how you considered renewal rates when including term licenses in your ARR calculations. In your response, tell us your renewal rates for each period that you present ARR information. • Clarify for us how this measure is calculated. Specifically address how the up-front revenue received on an annual, quarterly or semi-annual term license is factored into your ARR calculation and provide examples to help explain such calculations. • Tell us how multi-year contracts are factored into your calculations and why inclusion of such contracts is appropriate. In your response, tell us the amount of revenue recognized from multi-year contracts for each period presented and the typical terms of such arrangements.
See the reply above.
You state throughout the filing that dollar-based net retention rate was greater than 130% for each of the last eight fiscal quarters. Please tell us and revise to disclose the actual rate for each period presented and discuss any significant fluctuations in such rates. Similar revisions should be made with regards to your dollar-based gross retention rate.Rest of the question
Please also revise to provide the actual customer count for each period presented rather than referring to, for example, more than 6,000 customers.
See the reply above.
You provide the number of customers with ARR greater than $100,000 and $1.0 million for each of the last three fiscal years. You also state that sales to larger customers involve additional risks such as longer sales cycles, more complex customer requirements, substantial upfront costs and less favorable terms.Rest of the question
Please tell us and disclose the percentage of revenue generated from your customers with greater than $100,000 and $1.0 million of ARR to provide context for this information.
See the reply above.
To avoid giving undue prominence to your non-GAAP financial measures, please move this section so that it follows the results of operations disclosures. Refer to Item 10(e)(1)(i)(A) of Regulation S-K and Question 102.10 of the non-GAAP C&DIs.
See the reply above.
Please revise your critical accounting policies to present your analysis of the uncertainties involved in applying an accounting principle at a given time or the variability that is reasonably likely to result from its application over time. Refer to Section V of SEC Release No. 33-8350.
See the reply above.
Please file your material leases as exhibits to the registration statement. See Item 601(b)(10) of Regulation S-K.
See the reply above.
You note that all of your directors currently serve on the board pursuant to the provisions of a voting agreement between the company and several of its stockholders. Please file the voting agreement as an exhibit to the registration statement. Refer to Item 601(b) of Regulation S-K.
See the reply above.
Please provide the 2020 and 2021 compensation information for your named executive
See the reply above.
We note that your forum selection provision identifies the federal district courts of the United States of America as the exclusive forum for claims arising under the Securities Act. Please disclose that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder.Rest of the question
As you noted, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.
See the reply above.
You state that you offer your platform via SaaS arrangements. Please tell us how much revenue you generate from such arrangements. Clarify for us, and disclose if material, how you account for such arrangements, including whether you consider the license to be a distinct performance obligation. Refer to ASC 606-10-25-19 through 22.
See the reply above.
You disclose that “license revenue is recognized at the point in time when the customer is able to use and benefit from the software…” Please clarify whether your reference to “the customer” means a channel partner or end-user customer. Also, tell us how you determine when the customer has obtained control. Refer to ASC 606-10-25-30 and 606-10-50-19.
See the reply above.
We note that you have applied the practical expedient in ASC 340-40 in accounting for your contract acquisition costs. We further note that amortization of such costs is recognized consistent with the pattern of revenue recognition for the respective performance obligations.Rest of the question
Considering you typically enter into annual contracts and recognize the revenue from the license obligation up-front please tell us the following: • Clarify which contracts your deferred contract acquisition costs relate; • Tell us the amount of costs expensed as incurred pursuant to the practical expedient for each period presented; and • Considering the commissions paid on renewal contracts are commensurate with what is paid on the initial contract, please tell us whether the "period of benefit" ever exceeds the contract term and if so, why.
See the reply above.
Please provide us with a breakdown of all stock options and restricted stock awards granted during fiscal 2021 or after and include the fair value of the underlying common stock at the date of such grants. To the extent there were any significant fluctuations in the fair values from period-to-period, describe for us the factors that contributed to these fluctuations, including any intervening events within theRest of the question
company or changes in your valuation assumptions or methodology, underlying common stock used to value such awards as determined by your board of directors.
See the reply above.
Please provide us with copies of all written communications, as defined in Securities Act Rule 405, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Securities Act Section 5(d), whether or not they retain copies of the communications.
See the reply above.
Please explain to us why shares of Class A stock issuable upon the vesting and settlement of RSUs that have satisfied both the performance and service conditions are excluded from the total number of Class A common stock outstanding after the offering. Similarly, tell us why these shares were excluded from your pro forma Capitalization disclosures and pro forma Dilution calculations.
No reply letter found.
We note your response to prior comment 2. Please revise your disclosures in footnote 3 and elsewhere to clarify that the stock-compensation expense adjustment relates to unrecognized compensation expense for RSUs for which both the performance-based and service-based vesting condition will be satisfied in connection with this offering.Rest of the question
Also, disclose here the number of shares related to RSUs that will vest upon effectiveness of the offering.
No reply letter found.
We note your response to prior comment 4. Please explain and/or revise your disclosures as necessary to address the following: • Provide us with your renewal rates for each period presented. • Clarify that ARR is calculated from invoiced amounts as explained in your response.Rest of the question
• Describe how ARR differs from GAAP revenue and specifically address the timing of revenue recognition related to the license performance obligation. • Disclose here that ARR does not reflect any actual or anticipated reductions of revenue due to contract non-renewals or service cancellations and discuss any limitations present as a result. • To provide context to your disclosure, discuss any costs incurred to obtain renewals that this metric does not contemplate. • Considering ARR is calculated based on invoiced amounts and not actual annualized GAAP revenue, please tell us how you considered renaming this measure to more appropriately reflect what it represents. • You state that this metric illustrates your ability to acquire new subscription customers and to maintain and expand your relationship with existing subscription customers. In light of this, revise to disclose how much of the ARR growth rate is due to new customers separately from existing customers. • Explain further to us how additional license agreements are factored into ARR and provide an example of such calculation. Also, tell us the amount of revenue recognized from additional license agreements for each period presented.
No reply letter found.
We note your response to prior comment 5. Please tell us the actual dollar based net and gross retention rates for each period presented. To the extent you continue to disclose this metric, to add context to your disclosed measures, revise to disclose the actual rates for each period presented and explain any significant fluctuations in such rates between periods.
No reply letter found.
Please revise the graphics at the forefront of the registration statement to present a balanced picture of the company’s financial health. In this respect, we note that the company has had increasing net losses during the last two years and indication of such should be given equal prominence with the current presentation emphasizing revenue growth. Refer to Securities Act Forms C&DI 101.02.
No reply letter found.
Please clarify your bullet on page 14 indicating shares that will be outstanding after the IPO excludes shares of Class A common stock issuable upon the vesting and settlement of RSUs granted after January 31, 2021 for which the performance-based vesting condition will be satisfied in connection with this offering. Specifically, clarify whether these shares are still subject to service based vesting provisions.Rest of the question
Alternatively, tell us your basis for excluding these shares from the total shares to be outstanding after this offering.
to the Staff’s comment, the Company has revised the disclosure on pages 14, 15, 68 and 71 of the RegistrationRead in the reply
Please explain your disclosures on page 15 where you state that the conversion of all outstanding shares of convertible preferred stock does not include the 12,043,202 shares of series F convertible preferred stock issued and sold in February 2021. In this regard, it appears that you are including such issuance in your pro forma per share and capitalization disclosures.
The Company respectfully acknowledges the Staff’s comment and has revised the disclosure on pageRead in the reply
15 of the Registration Statement to include the automatic conversion of 12,043,202 shares of series F convertible preferred stock.
You state in your response to prior comment 2 that stock-based compensation related to unrecognized compensation expense for RSUs that will vest upon effectiveness of this offering are excluded from pro forma net loss per share as such amounts are not expected to have a recurring impact on your consolidated financial statements.Rest of the question
Please tell us how you considered the updated guidance in Article 11-02(b)(6) of Regulation S-X or revise your pro forma per share calculations accordingly. Refer to Section II.F of Sec Release No. 33-10786. In addition, tell us why you refer to an adjustment to additional paid-incapital in note (3) to your pro forma per share calculations or revise to remove.
The Company respectfully acknowledges the Staff’s comment. TheRead in the reply
Company advises the Staff that, in accordance with the updated guidance in Article 11-02(a)(6) of Regulation S-X, it will include in the pro forma per share calculations the stock-based compensation related to the unrecognized compensation expense for RSUs for which the service-based vesting condition will be satisfied and the performance-based vesting condition will be satisfied in connection with this offering.
For the fiscal year ended January 31, 2021, in the computation of the pro forma adjustment on stock-basedRest of the answer
compensation expenses related to RSUs for which the service-based vesting condition will be satisfied and the performance-based vesting condition will be satisfied in connection with this offering, the Company assumes that the offering was effective at the beginning of the most recently completed fiscal year included in the registration statement.
The Company has revised the disclosure on page 17 of the Registration Statement to clarify that the pro forma per share calculations include the stock-based compensation related to the unrecognized compensation expense for RSUs for which the service-based vesting condition will be satisfied and the performance-based vesting condition will be satisfied in connection with this offering.
The Company further respectfully advises the Staff that it has revised note (3) on page 17 and its disclosure on pages 18, 66 and 69 of the Registration
Statement to remove the adjustment to additional paid-in capital from the pro forma per share calculations.
Please revise your per share pro forma earnings per share presentation to reflect the Series F financing as it appears to have a material impact on the number of shares that will convert to common upon your initial public offering. Refer to Article 11-01(a)(8) of Regulation S-X.
to the Staff’s comment, the Company has revised the disclosure on page 17 of the AmendedRead in the reply
Registration Statement to include the absolute number of shares of the Company’s Series F preferred stock within the denominator of its per share pro forma earnings per share presentation as of February 1, 2020.
Please provide us with the calculations that support your pro forma net tangible book value and tell us how you factored deferred contract acquisition costs into your calculations. To the extent you did not consider such assets to be intangible assets, please explain or revise your calculations as necessary.
to the Staff’s comment, the Company has revised the disclosure on page 69 of the AmendedRead in the reply
Registration Statement to exclude deferred contract acquisition costs from its pro forma net tangible book value calculations.
As also discussed with the
Staff, the Company has revised the disclosure on pages 15, 17, 18, 66, 69 and 175 of the Amended Registration Statement to add the number of shares subject to restricted stock units that are being net settled in connection with this offering.